Hepatitis C Retreatment With First-Line Direct Acting Antiviral Drugs.

Amit Goel,Harshita Katiyar, Mayank,Prachi Tiwari,Sumit Rungta,Abhai Verma,Amar Deep, Asari Sana,Praveer Rai,Rakesh Aggarwal

Journal of Clinical and Experimental Hepatology（2023）

引用 0|浏览10

暂无评分

摘要

HCV retreatment could be a treatment option if second-line anti-HCV drugs are not available. Successful retreatment could be achieved, in a large proportion, with the use of first-line drugs for 24 weeks with ribavirin and swapping of pangenotypic/genotype-specific regimens (NCT03483987).

查看译文

关键词

HCV retreatment,direct acting antivirals,hepatitis C virus,sofosbuvir,velpatasvir

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要